(Q28251794)
Statements
Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms (English)
0 references
February 2012
0 references
50
0 references
2
0 references
353-62
0 references
2 references
1 reference
1 reference
1 reference
1 reference
1 reference